CD276 and experimental autoimmune encephalomyelitis: Independent studies utilizing either protein blockade or gene-knockout mice have reported that B7-H3 ameliorates graft-versus-host disease, prolongs cardiac allograft survival, reduces airway hypersensitivity, and delays experimental autoimmune encephalomyelitis onset, in particular by dampening the Th1 response [35–37].